All In Biotech

Investigational drug · Phase 2

TL938

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Colorectal Cancer Metastatic, Advanced Colorectal Cancer.

Phase 2

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

1

Any phase or sponsor naming "TL938"

First trial start

2025

May 13, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TL938", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Colorectal Cancer Metastatic
  • Advanced Colorectal Cancer

Approved drugs for the same conditions: Colorectal cancer · Oncology

Largest trials

Live from ClinicalTrials.gov: studies naming "TL938" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Colorectal Cancer Metastatic

  • TunlametinibPhase 32 trials

    Shanghai Kechow Pharma, Inc. · Colorectal Cancer Metastatic, Melanoma

  • EB-DUO-CAR-NK-CEAGCCPhase 22 trials

    Beijing Biotech · Colorectal Cancer Metastatic, Adenocarcinoma of Colon, Colorectal Cancer

  • HDM2017Phase 22 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · CRC, Colorectal Cancer, Colorectal Cancer Metastatic

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • DKN-01LY2812176Phase 21 trial

    Leap Therapeutics, Inc. · Colorectal Cancer, Colorectal Adenocarcinoma, Colo-rectal Cancer

  • ImofinostatABT-301, MPT0E028Phase 21 trial

    Anbogen Therapeutics, Inc. · Colorectal Cancer (Diagnosis), Colorectal Cancer Metastatic, Colorectal Cancer (CRC)

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.